Inventor

ZENS KYRA D

US11 patents

⚠️ This page may combine multiple inventors who share the name “ZENS KYRA D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SQUIBB & SONS LLC

10 patents

US10344089B2Jul 9, 2019

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC25 citations97

US11001630B2May 11, 2021

Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC10 citations94

US10988535B2Apr 27, 2021

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC10 citations94

US10988536B2Apr 27, 2021

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC10 citations94

US11530267B2Dec 20, 2022

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC2 citations84

US11512130B2Nov 29, 2022

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC2 citations84

US11236163B2Feb 1, 2022

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC4 citations84

US11236165B2Feb 1, 2022

Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC4 citations84

US11236164B2Feb 1, 2022

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

SQUIBB & SONS LLC4 citations84

US9499632B2Nov 22, 2016

Human antibodies that bind CD22 and uses thereof

SQUIBB & SONS LLC8 citations82

KING DAVID JOHN

1 patent

US8481683B2Jul 9, 2013

Human antibodies that bind CD22 and uses thereof

KING DAVID JOHN31 citations87